An Open-label Study to Assess Brain Uptake and Safety of Flutemetamol F 18 Injection in Japanese Subjects With Probable Alzheimer's Disease, Subjects With Amnestic Mild Cognitive Impairment and Healthy Volunteers
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- Sponsors GE Healthcare
- 01 Apr 2017 Results published in the Annals of Nuclear Medicine.
- 07 Jul 2016 New trial record